Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?

BACKGROUND: Visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection remains a major problem in Ethiopia, India, and Brazil. Tuberculosis (TB), a treatable factor, could contribute to high mortality (up to 25%) in VL-HIV coinfection. However, the current evidence on the prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales: van Griensven, Johan, Mohammed, Rezika, Ritmeijer, Koert, Burza, Sakib, Diro, Ermias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925430/
https://www.ncbi.nlm.nih.gov/pubmed/29732379
http://dx.doi.org/10.1093/ofid/ofy059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925430/
https://www.ncbi.nlm.nih.gov/pubmed/29732379
http://dx.doi.org/10.1093/ofid/ofy059

Ejemplares similares